ATE84065T1 - Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i. - Google Patents

Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i.

Info

Publication number
ATE84065T1
ATE84065T1 AT87114733T AT87114733T ATE84065T1 AT E84065 T1 ATE84065 T1 AT E84065T1 AT 87114733 T AT87114733 T AT 87114733T AT 87114733 T AT87114733 T AT 87114733T AT E84065 T1 ATE84065 T1 AT E84065T1
Authority
AT
Austria
Prior art keywords
expression vector
igf
growth factor
human insulin
met
Prior art date
Application number
AT87114733T
Other languages
German (de)
English (en)
Inventor
Ueda Ikuo
Niwa Mineo
Saito Yoshimasa
Ishii Yoshinori
Kitaguchi Tadashi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE84065T1 publication Critical patent/ATE84065T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT87114733T 1986-10-09 1987-10-08 Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i. ATE84065T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24070286 1986-10-09
EP87114733A EP0264074B1 (en) 1986-10-09 1987-10-08 Expression vector for insulin-like growth factor i

Publications (1)

Publication Number Publication Date
ATE84065T1 true ATE84065T1 (de) 1993-01-15

Family

ID=17063431

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87114733T ATE84065T1 (de) 1986-10-09 1987-10-08 Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i.

Country Status (5)

Country Link
EP (1) EP0264074B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE84065T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3783305T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2044887T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3007491T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0227993A (ja) * 1988-07-15 1990-01-30 Nippon Shinyaku Co Ltd ｈＥＧＦの製法
KR920003787B1 (ko) * 1990-03-05 1992-05-14 한국과학기술 연구원 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법
ATE222117T1 (de) * 1990-05-30 2002-08-15 Harvard College Kombination aus igf-i und tgf-beta zur knochenregenerierung
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
JPH10504971A (ja) * 1994-09-08 1998-05-19 カイロン コーポレイション インスリン様増殖因子の改善された生産方法
US5712249A (en) * 1994-09-08 1998-01-27 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK108685A (da) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co Vaekstfaktor i
DK151585D0 (da) * 1985-04-03 1985-04-03 Nordisk Gentofte Dna-sekvens
EP0440311A1 (en) * 1985-06-20 1991-08-07 Fujisawa Pharmaceutical Co., Ltd. A process for the production of alpha-human atrial natriuretic polypeptide

Also Published As

Publication number Publication date
GR3007491T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-07-30
EP0264074A2 (en) 1988-04-20
EP0264074A3 (en) 1989-10-25
DE3783305D1 (de) 1993-02-11
EP0264074B1 (en) 1992-12-30
DE3783305T2 (de) 1993-05-19
ES2044887T3 (es) 1994-01-16

Similar Documents

Publication Publication Date Title
EP0156355A3 (en) Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
EP0244234A3 (en) Transformation of trichoderma
CA2094027A1 (en) Osteogenic peptides
BG60053B2 (bg) Метод за повишаване способността за получаване на антибиотик
HUP9903856A2 (hu) Új Escherichia coli törzsek,eljárások előállításukra és felhasználásuk fermentációs folyamatokban L-treonin előállítására
ATE107958T1 (de) Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
EP0228449A4 (en) FIBROBLAST GROWTH FACTOR.
ATE182174T1 (de) Gliazellen-aktivierender faktor und dessen herstellung
AU3530589A (en) Osteogenic devices
CZ738982A3 (en) Human immune interferon and derivative thereof, separated dna with sequence encoding human immune interferon, recombinant cloning vector, replicable expression vector, recombinant micro-organism or cellular culture, pharmaceutical preparation, process for preparing the human immune interferon and its use
CA2066618A1 (en) Plasmids containing dna encoding the amino acid sequence of tcf-ii, transformed cells with the plasmids, and production method of biologically active substance using the transformed cells
ZA918462B (en) Expression system.
ZA887773B (en) Interleukin-7
AU4683489A (en) Tgf-beta 1/beta 2: a novel chimeric transforming growth factor-beta
AU3329989A (en) Viper venom polypeptides and genetic expression
ATE84065T1 (de) Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i.
PT731811E (pt) Chaperonina 10
IE801912L (en) Gaming machine
EP0643133A3 (de) Rekombinante D-Hydantoinase, Verfahren zur Herstellung und Verwendung.
AU7151687A (en) Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same
NO175318C (no) Hybridgen for veksthormonfrigjörende faktor, replikerbar mikrobiell ekspresjonsvektor inneholdende et slikt gen, samt mikroorganisme transformert med en slik vektor og hybridpolypeptid som inneholder en Trp-GRF
DE3479816D1 (en) A promotor and use thereof
AU1090688A (en) Synthetic porcine growth hormone
DK502786A (da) Fremgangsmaade til fremstilling af en vaekstfaktor
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee